The role of stem cells in hypertrophic scar improvement
Not Applicable
- Conditions
- Hypertrophic Scar.Hypertrophic scar
- Registration Number
- IRCT2012070710201N1
- Lead Sponsor
- Tehran University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with hypertrophic scar. Exclusion criteria: Patient's reluctance to continue cooperation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vascularity. Timepoint: 3, 6 months and 1 year. Method of measurement: Inspection.;Pigmentation. Timepoint: 3 , 6 months and 1 year. Method of measurement: Inspection.;Pliability. Timepoint: 3 , 6 months and 1 year. Method of measurement: palpation.;Height. Timepoint: 3 , 6 months and 1 year. Method of measurement: Measurement with caliper.;Vancouver Scoring System. Timepoint: 3 , 6 months and 1 year. Method of measurement: Inspection and Palpation.
- Secondary Outcome Measures
Name Time Method Scar Tissue Increment. Timepoint: 3 , 6 months and 1 year. Method of measurement: Inspection and measurment with caliper.;Pruritus. Timepoint: 3 , 6 months and 1 year. Method of measurement: Patient Expression.;Burning. Timepoint: 3 , 6 months and 1 year. Method of measurement: Patient Expression.;Injection Site Infection and Inflammation. Timepoint: Up to 1 month. Method of measurement: Diagnosis by physician.